אנסטרוז

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

ANASTROZOLE 1 MG

Disponible depuis:

TARO INTERNATIONAL LTD

Code ATC:

L02BG03

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

SYNTHON B.V., NETHERLANDS

Groupe thérapeutique:

ANASTROZOLE

indications thérapeutiques:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Date de l'autorisation:

2010-06-01